One of these suggested stocks features a dividend yield topping 10%.

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?

Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc. (NYSE:PFE) announced on January 10 ...

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. With 66% stake, ...

Dividend-paying stocks can really boost an individual investor's portfolio. If you're in the market for some no-brainer ...

Pfizer's (NYSE:PFE) stock is up by 4.7% over the past three months. Given that the markets usually pay for the long-term ...

The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the ...

Novavax shares are trading higher Tuesday after the company announced it entered into a license agreement with Pfizer for ...

Shares of US biotech Novavax were up 9% at $8.72 by midday on Tuesday, after it revealed it has entered into a license ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today, the UK health technology assessor, National Institute ...